AtonRa Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $794K | Sell |
3,433
-424
| -11% | -$98.1K | 1.58% | 9 |
|
|
2023
Q3 | $563K | Sell |
3,857
-901
| -19% | -$132K | 1.18% | 21 |
|
|
2023
Q2 | $1.1M | Sell |
4,758
-550
| -10% | -$127K | 1.7% | 10 |
|
|
2023
Q1 | $1.29M | Sell |
5,308
-398
| -7% | -$96.4K | 1.88% | 7 |
|
|
2022
Q4 | $1.66M | Sell |
5,706
-1,543
| -21% | -$448K | 2.11% | 4 |
|
|
2022
Q3 | $471K | Sell |
7,249
-35
| -0.5% | -$2.27K | 0.46% | 92 |
|
|
2022
Q2 | $521K | Buy |
+7,284
| New | +$521K | 0.48% | 98 |
|